Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Carcinogenesis
54%
Overall Survival
52%
Whole Cell
48%
Gene Signature
48%
Eicosanoid Receptor
48%
G2 Phase
48%
Cell Cycle Progression
42%
Immune Checkpoints
36%
Epigenetics
35%
Transcription
33%
Signal Transduction
33%
Surface Property
32%
Genetics
32%
Cell Division
32%
Gene Expression
31%
Protein Expression
29%
Cyclin D1
29%
Prolyl Isomerase
29%
Stem Cell
28%
Tumor Suppressor Protein
28%
Drug Resistance
28%
Cell Death
28%
Multigene Family
27%
Cell Cycle
27%
Small Hairpin RNA
27%
Cadherin
24%
Creatinine
24%
Oxysterol-Binding Protein
24%
Tumor Spheroid
24%
Discoidin Domain
24%
Immunoglobulin Domain
24%
Oncogene
24%
ANGPTL4
24%
Survival Rate
24%
Lipid Storage
24%
Messenger RNA
24%
Wnt Signaling Pathway
24%
Alanine Aminopeptidase
24%
Leucyl Aminopeptidase
24%
Autophagy
24%
Mitogen-Activated Protein Kinase
24%
Long Non-Coding RNA
24%
Tumor Marker
24%
Aryl Hydrocarbon Receptor
24%
S Phase
24%
PD-L1
24%
RUNX3
24%
Phosphopeptide
24%
Topoisomerase
24%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
92%
Malignant Neoplasm
88%
Chemotherapy
59%
Non Small Cell Lung Cancer
51%
Esophageal Squamous Cell Carcinoma
48%
Epidermal Growth Factor Receptor
34%
Paclitaxel
30%
Uvomorulin
29%
Cisplatin
29%
Disintegrin
27%
Metalloproteinase
27%
Uterine Cervix Cancer
24%
Hedgehog
24%
Ovary Cancer
24%
Aromatic Hydrocarbon Receptor
24%
Nilotinib
24%
Phosphotransferase
24%
Tirzepatide
24%
Claudin 5
24%
Chemoradiation Therapy
24%
Non Insulin Dependent Diabetes Mellitus
24%
Pharmacotherapy
24%
microRNA 200
24%
Alanine Aminopeptidase
24%
Tumor Marker
24%
Breast Cancer
24%
Immunogenic Cell Death
24%
Carcinogenesis
24%
DNA Topoisomerase
24%
Lung Adenocarcinoma
24%
STAT3 Protein
24%
Nanozymes
24%
Tirapazamine
24%
Hypoxia
24%
Mussel
24%
Nanocarrier
24%
Molybdenum Disulfide
24%
Photothermal Therapy
24%
Hydrogen Peroxide
21%
Disease
20%
Cyclin D1
18%
Vasculotropin
18%
Primary Tumor
15%
Investigational Drug
12%
Bladder Tumor
12%
Lung Metastasis
12%
Cancer Mortality
12%
Host Factor
12%
Receptor
12%
Prostaglandin E2
12%
Medicine and Dentistry
Neoplasm
46%
Bladder Cancer
30%
Discoidin Domain Receptor
29%
Cancer Cell
28%
Programmed Cell Death
28%
Non Muscle Invasive Bladder Cancer
28%
Tumor Cell
24%
Cell Death
24%
Cancer Growth
24%
Ovarian Cancer
24%
Radical Hysterectomy
24%
Mitochondrion
24%
Cervical Cancer
24%
Phosphotransferase
24%
Nilotinib
24%
Tumor Spheroid
24%
Disintegrin
24%
Blood-Retinal Barrier
24%
Claudin 5
24%
Amino Terminal Sequence
24%
Bladder Tumor
24%
Tumor Microenvironment
24%
Mesenchymal Stem Cell
24%
Neoadjuvant Chemotherapy
24%
Metalloproteinase
24%
Signal Transduction
24%
Mitogen-Activated Protein Kinase
24%
Transitional Cell Carcinoma
24%
Cancer Stem Cell
24%
Tumor Differentiation
24%
Collagen Type 1
24%
Immunogenic Cell Death
24%
Muscle Invasive Bladder Cancer
24%
Malignant Peripheral Nerve Sheath Tumor
24%
Necroptosis
24%
Autophagy
24%
Extracellular Matrix
22%
Treatment Response
13%
Bladder
13%
Overall Survival
12%
Dental Pulp
12%
Protein Expression
12%
Investigational Drug
12%
Negative Feedback
12%
Prostaglandin E2
12%
Stroma
9%
Malignant Neoplasm
8%
Gene Expression
8%
Bone Development
8%
Obstetrics
8%
